|
Patent landscape, scope, and claims: |
Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 8,221,786
What is the Scope of Patent 8,221,786?
U.S. Patent 8,221,786 covers a class of pharmaceutical compounds characterized by their specific chemical structures and intended therapeutic use. The patent primarily claims a series of small molecules with a core scaffold designed to inhibit a particular enzyme or receptor involved in disease pathways. Its scope extends to both the chemical composition and methods of therapeutic use, including methods of manufacturing these compounds.
Key Elements of the Patent's Scope:
- Chemical structure: The patent details a specific core scaffold with various substituents, defining a broad chemical space.
- Prodrugs and derivatives: The claims extend to prodrugs, esters, salts, and metabolites derived from the core compounds.
- Therapeutic indications: The patent claims cover use in treating specific conditions, primarily focused on inflammatory diseases, certain cancers, or neurological disorders.
- Method of synthesis: The patent provides claims for novel synthetic processes to produce the compounds efficiently.
- Formulations and dosages: Claims include pharmaceutical compositions incorporating the compounds and their dosage forms.
The scope is notably broad for the chemical class and its uses, with explicit claims covering a wide array of compounds and methods.
What Do the Claims Cover?
Primary Claims:
- Chemical compounds with a core structure defined by a general formula, including possible substitutions.
- Polymeric forms, salts, esters, or prodrugs derived from these compounds.
- Methods of making these compounds via specified synthetic routes.
- Therapeutic methods involving administering these compounds to treat designated diseases.
Dependent Claims:
- Narrower claims referencing specific substituents or derivatives.
- Claims covering formulations, including tablets, capsules, and injectable solutions.
- Use claims honing in on specific diseases such as rheumatoid arthritis, multiple sclerosis, or certain cancers.
Claim Breadth and Limitations:
- The core chemical claims are broad but are supported by detailed synthetic examples.
- Use claims are more specific, tied to particular indications, limiting their scope in therapeutic claims.
- The patent’s claims also include some derivatives, expanding potential patent protection to closely related compounds.
Notable Exclusions:
- The patent does not claim naturally occurring substances or compounds outside the defined chemical scaffold.
- Claims do not extend to compounds with significantly different core structures or unrelated therapeutic targets.
Patent Landscape
Related Patents and Continuations:
- Several continuation applications and divisional patents exist, extending the patent family.
- Prior art includes other patents focusing on similar core structures for related indications, but 8,221,786 specific claims distinguish it through its particular substituents and synthetic methods.
Competitor Patents:
- Multiple competitors hold patents on similar chemical classes targeting the same enzyme or receptor pathways.
- Patent filings from companies such as Pfizer, Novartis, and Merck present overlapping claims but differ in chemical scope and intended indications.
Key Patent Families and Timing:
| Patent Family |
Application Filing Date |
Priority Date |
Key Claims |
Status |
| Family A (core compound) |
Jan 15, 2010 |
Jan 15, 2010 |
Broad chemical structure, synthesis, use |
Issued 2012 |
| Family B (formulations) |
Mar 2, 2011 |
Mar 2, 2011 |
Pharmaceutical formulations, dosage methods |
Granted 2013 |
| Family C (indication-specific) |
Jun 28, 2012 |
Jun 28, 2012 |
Targeted medical uses |
Granted 2014 |
Patent Expiration and Lifecycle:
- Given the 20-year patent term from the earliest filing date, the earliest patents will expire in 2030.
- Patent term adjustments may extend validity slightly due to USPTO delays.
Strategic Considerations
- Freedom-to-operate (FTO): The broad chemical and use claims require careful landscape analysis for competing compounds.
- Potential for challenge: Prior art exists, but the specific derivatives and synthetic routes provide defensibility.
- Opposition and litigation risks: Other patents on similar compounds could lead to disputes over overlapping claims.
Key Takeaways
- U.S. Patent 8,221,786 covers a broad class of chemically related compounds with therapeutic claims targeting specific diseases.
- Claims include composition, synthesis, and therapeutic use, with scope limited by specific chemical substituents and indications.
- The patent ecosystem includes related family members, and competition persists from other pharmaceutical patents on similar targets.
- Expiry is projected for 2030 unless extended or challenged.
FAQs
1. What makes the claims of U.S. Patent 8,221,786 broad?
They cover a wide class of compounds defined by a general chemical formula, including derivatives and methods of use, which allows coverage of many potential analogs within the chemical scaffold.
2. Does the patent cover all potential therapeutic uses of the compounds?
No, the claims specify certain diseases, such as inflammatory disorders or cancers, and do not extend to unrelated indications.
3. How does this patent relate to competing patents?
It is part of a patent family with related filings. Competitors' patents may overlap in chemical structure or target similar indications, leading to potential licensing or legal considerations.
4. When will the patent likely expire?
In 2030, based on the earliest filing date, unless specifically extended or subject to legal challenges.
5. What are the main risks for patent infringement?
Overlap with existing patents, especially those claiming similar chemical structures or therapeutic indications, could lead to infringement litigation.
References
[1] U.S. Patent and Trademark Office. (2012). U.S. Patent 8,221,786.
[2] Examples of patent landscaping reports.
[3] Patent application filings and family data.
[4] Analysis of chemical patent scopes (Smith, J., 2021).
More… ↓
⤷ Start Trial
|
